Search results
Results from the WOW.Com Content Network
Anthracimycin is a polyketide antibiotic discovered in 2013. Anthracimycin is derived from marine actinobacteria . In preliminary laboratory research, it has shown activity against Bacillus anthracis , [ 1 ] the bacteria that causes anthrax , and against methicillin-resistant Staphylococcus aureus (MRSA).
Raxibacumab [2] is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax.Its efficacy has been proven in rabbits and monkeys. [3] In December 2012 raxibacumab was approved in the United States for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax ...
Anthrax is an infection caused by the bacterium Bacillus anthracis or Bacillus cereus biovar anthracis. [2] Infection typically occurs by contact with the skin, inhalation, or intestinal absorption. [9] Symptom onset occurs between one day and more than two months after the infection is contracted. [1]
Two separate patients who were prescribed a popular class of antibiotic told WFTS the drug came with severe side effects. For both women, the family of antibiotics known as fluoroquinolones ...
Bacillus anthracis is a gram-positive and rod-shaped bacterium that causes anthrax, a deadly disease to livestock and, occasionally, to humans. It is the only permanent ( obligate ) pathogen within the genus Bacillus .
[1] [2] It contains the three antibiotics neomycin, polymyxin B, and bacitracin. [1] It is for topical use. [3] [4] Possible side effects include itchiness and skin rash, [5] and in rare cases hearing loss. [5] It is relatively broad spectrum, being effective against both Gram-negative and Gram-positive bacteria. [2]
Toxic shock syndrome (TSS) is a condition caused by bacterial toxins. [1] Symptoms may include fever, rash, skin peeling, and low blood pressure. [1] There may also be symptoms related to the specific underlying infection such as mastitis, osteomyelitis, necrotising fasciitis, or pneumonia.
Drugs which inhibit Cytochrome P450 or other oxidases may reduce clearance of anthracyclines, prolonging their circulating half-life which can increase cardiotoxicity and other side effects. [57] As they act as antibiotics anthracyclines can reduce the effectiveness of live culture treatments such as Bacillus Calmette-Guerin therapy for bladder ...